Last reviewed · How we verify
HSK39004 inhalation suspension
HSK39004 inhalation suspension is a Small molecule drug developed by Haisco Pharmaceutical Group Co., Ltd.. It is currently in Phase 2 development. Also known as: Ohtuvayre inhalation suspension.
At a glance
| Generic name | HSK39004 inhalation suspension |
|---|---|
| Also known as | Ohtuvayre inhalation suspension |
| Sponsor | Haisco Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients (PHASE2)
- Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD) (PHASE2)
- Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HSK39004 inhalation suspension CI brief — competitive landscape report
- HSK39004 inhalation suspension updates RSS · CI watch RSS
- Haisco Pharmaceutical Group Co., Ltd. portfolio CI
Frequently asked questions about HSK39004 inhalation suspension
What is HSK39004 inhalation suspension?
HSK39004 inhalation suspension is a Small molecule drug developed by Haisco Pharmaceutical Group Co., Ltd..
Who makes HSK39004 inhalation suspension?
HSK39004 inhalation suspension is developed by Haisco Pharmaceutical Group Co., Ltd. (see full Haisco Pharmaceutical Group Co., Ltd. pipeline at /company/haisco-pharmaceutical-group-co-ltd).
Is HSK39004 inhalation suspension also known as anything else?
HSK39004 inhalation suspension is also known as Ohtuvayre inhalation suspension.
What development phase is HSK39004 inhalation suspension in?
HSK39004 inhalation suspension is in Phase 2.
Related
- Manufacturer: Haisco Pharmaceutical Group Co., Ltd. — full pipeline
- Also known as: Ohtuvayre inhalation suspension
- Compare: HSK39004 inhalation suspension vs similar drugs
- Pricing: HSK39004 inhalation suspension cost, discount & access